Lung Cancer Clinical Trials 2023

What is Lung Cancer?

Cancer is a known disease of the body’s cells where they abnormally grow, increase, or multiply. In lung cancer, uncontrollable growth of cells caused by this disease first starts and gradually seizes the opportunity to spread into other organs. It can also be the other way around, where cancer from other organs can begin and steadily make its way to the lungs. There are two (2) types of Lung Cancer.

Small Cell Lung Cancer (SCLC), also called “Oat Cell Cancer,” is the second most common cancer in the world. Studies show that 15 out of 100 (about 15%) patients in the UK diagnosed with lung cancer have this type. It is usually caused by continuously smoking for long periods of time.

Non-small Cell Lung Cancer (NSCLC), this type of lung cancer is the most common one. Around 85 out of 100 (about 85%) patients in the UK diagnosed with lung cancer have this type. Three (3) main subtypes of this lung cancer are Adenocarcinoma, Squamous Cell Carcinoma, and Large Cell Carcinoma.

What Are Lung Cancer Clinical Trials?

Cancer patients or those diagnosed with cancer undergo clinical trials with the goal of securing an effective and safe medicinal advancement in order for treatments to work in battling the disease. Lung Cancer patients, for example, are presented with the choice of undergoing several clinical trials by their doctor/s. Now, this depends on the patient’s choice and interest if they want to continue and have these clinical trials or if they thoroughly discussed with their doctor/s that they are viable in taking these medical trials.

Why Is Lung Cancer Being Studied In Clinical Trials?

Since lung cancer is the third most common kind of cancer in the US and one of the most common globally, it is an urgent responsibility of health professionals to look for better ways through research and study with the help of volunteers. Throughout the years, clinical trials on different kinds of diseases have successfully made progress and advancement in the field of medicine, spotting alternatives and as well as cures.

How Does Lung Cancer Treatment Work?

The reason that lung cancer has different types also means that treatment varies in between what type you are diagnosed with. So, to start the treatment, a diagnosis must be first conducted through a number of tests. It is vital to analyze the disease further because every patient is different from the others, even if they have the same complications. This is also to rule out some possibilities that may endanger the patient’s life, or that can bring more harm to them along the line.

Heath professionals, equipped with their distinctive specialties, have pooled their resources together in order to battle one of the world’s most common cancer found in all walks of life. Pulmonologists, doctors who have expertise in lung diseases, sometimes work in unison to combine their knowledge and capabilities for lung cancer treatments. Surgeons and Thoracic surgeons who are experts in medical operations have come to work together for successful operations to foster. Lastly, medical oncologists and radiation oncologists who have different fields in treating lung cancer are handing out ideas to each other to save a patient’s life.

Through the collective work of these health professionals and remarkable individuals, treatments such as surgery, chemotherapy, targeted therapy, and radiation therapy are presented on the table as relevant means in order to battle lung cancer and for treatments to work.

What are some of the breakthrough clinical trials involving Lung Cancer?

2020: A study involved a targeted therapy treatment called _KRAS, _which is a cancer-causing protein that has been known since it was discovered by scientists at the National Cancer Institute in 1982. The KRAS Inhibitor Sotorasib for Lung Cancer is a significant breakthrough for lung cancer science and treatment; it was also granted a Breakthrough Therapy Designation by the US food and drug association last December of 2020.

Who Are The Key Opinion Leaders In Lung Cancer Clinical Trial Research?

Dr. Benjamin Besse, is a full-time cancer specialist and also a well-known Professor in Medical Oncology at Paris-Saclay University, located in Orsay, France. His main research revolves around molecular abnormalities, and he has authored more than 250 newspapers that are crucial for cancer clinical trials and treatments.

Top Hospitals For Lung Cancer Clinical Trials

MD Anderson Cancer Center is one of the largest cancer centers in the world and has pioneered numerous medical advances for many years. It also ranks first for having the most recorded research grants awarded by the National Cancer Institute.

Its cutting-edge technological research is one of this Cancer Center’s most remarkable feats. It boasts of its ability to transcript existing laboratory findings, making them into a much better treatment that is less traumatic and much more effective.

Check more hospitals offering tinnitus clinical trials below.

Top Treatments for Lung Cancer Clinical Trials

There are multiple known treatments for lung cancer, one of which is pembrolizumab which is a clinical trial consisting of three different treatments of locally advanced NSCLC.

This Lung Cancer treatment has been approved by the FDA and has adequate progress of more than 85%. This lung cancer clinical trial has been first recorded in 2011.

Top Cities for Lung Cancer Clinical Trials

Around the world, lung cancer clinical trials and treatments are not that uncommon at all. But according to Power’s data, Boston, Massachusetts, has the highest rate of Lung Cancer clinical trials, which is topped by Massachusetts General Hospital being the most active site for lung cancer clinical trials in the city.

How Many Lung Cancer Clinical Trials Are Open to Youth and/or Seniors?

Lung cancer in seniors is just as much as treatable as it is in youths. Since lung cancer clinical trials have been around for a long time, many new safe treatments and procedures have been evaluated and tested. But data collected from Power shows that there are 200+ lung cancer clinical trials available for those 18+ of age and at least two active lung cancer clinical trials for those 65 of age and above.

Most Recent Lung Cancer Clinical Trials

Although there are a lot of recent clinical trials for lung cancer because it is a globally known and common type of cancer, the data gathered from Power, Transbronchial Microwave Ablation is the most recent. It is a prospective, single-armed study that is revolving around the use of the NEUWAVE FLEX Microwave Ablation System and Accessories that is guided by the AURIS Monarch Platform accompanied by the use of computed tomography.